investordatabase.org

Readout Capital, LP

readoutcap.com Direct investor

Readout Capital is an investment firm focused on biotech, led by two co-founders with backgrounds in biotech investing and scientific research.

Readout Capital, LP is an investor. It invests directly in companies, in biotech.

Layer
Direct investor
Type
Other
Stage
Unknown
Sectors
biotech

Team, as Readout Capital, LP publishes it

  • Matthew Smith Co-Founder and Chief Investment Officer
  • James Dahlman, PhD Co-Founder and Chief Scientific Officer

Names and roles exactly as listed on readoutcap.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Readout Capital, LP publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 3990 · added 2026-09-03 · link last verified 2026-09-06 · confidence medium

Similar investors

Listed under